Personalized Medicine will create many answers and solutions in healthcare, but will we have the money to afford it? I post quite a bit about genomics and personalized medicine on the blog here and the one thing it has in common with the rest of healthcare is cost. The success of personalized...
Posted to
The Medical Quack .... by Barbara Duck
on 11-14-2008
Filed under: Medically Related, Technology, Insurance, Other Items of Interest, personalized medicine, healthcare, Medical Records, FDA, integration, CMS, Leavitt
Yes there is a genomics based test for this now, male and female. Inquiring minds want to know. If the answer comes back yes, then get a hold of some Propecia ©. If you have the gene variant, you have approximately a 70% chance of going bald, and the same in reverse if you do not have...
Posted to
The Medical Quack .... by Barbara Duck
on 10-28-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, personalized medicine, Genomics, Pharmacogenomics, DNA Testing, hair loss, Bald, Hair
The economy is also affecting some of the work and business design of genetic companies. DeCode is is Iceland with offices here in Illinois as well. Biotech companies are starting to feel the crunch as well, even those with breakthrough technology in personalized medicine and part of what...
Posted to
The Medical Quack .... by Barbara Duck
on 10-16-2008
Filed under: Medically Related, Other Items of Interest, personalized medicine, Genomics, Biotech, DeCode, DNA Testing, pharamcogenomics
However, their prescription drug unit faced the same problems as the rest of the Pharma industry. A smart investment in consumer products is helping hold things together for J and J. The consumer product division was purchased from Pfizer in 2006, which was the company purchased by Pfizer...
Posted to
The Medical Quack .... by Barbara Duck
on 10-14-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, personalized medicine, Genomics, Pharma, Pfizer, Phamaceuticals, Consumer Goods, J and J, Warner Lambert
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
on 10-13-2008
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
It has been a big day at Stanford with genomics, not only was the announcement made to better use sequencing to predict own syndrome, but they are also just about ready to receive their new genomic sequencing machine from Helicos. Earlier this year I interviewed Dr. Patrice Milos, Chief Science...
Posted to
The Medical Quack .... by Barbara Duck
on 10-07-2008
Filed under: Medically Related, Technology, Other Items of Interest, My Commentaries, personalized medicine, Genomics, healthcare, Electronic Medical Records, Biotech, cancer research, Research, Gene Sequencing, Disease, Stanford University, DNA Testing, Phamaceuticals, Helicos, Donation
We are getting closer to the $1,000 genome. Their business though is not to sell the machines, but rather to “wholesale” the process, in other words they will sequence only and offer no interpretations, which would be done by another company they would supply the sequencing information to. ...
Posted to
The Medical Quack .... by Barbara Duck
on 10-07-2008
Filed under: Medically Related, Technology, Other Items of Interest, personalized medicine, Genomics, Pharmacogenomics, DNA Testing, Sequencing, George Church, Complete Genomics